A Long-Term Follow-Up of Drug Treatment in Severe Hypertension

Abstract

Get full access to this article

View all access options for this article.

References

Bayliss

R. I. S.

Harvey-Smith

E. A.

(1962). Methyldopa in the treatment of hypertension. Lancet, 1, 763.

Blanshard

Essigman

(1961). Guanethidine and hydrochlorothiazide in the treatment of hypertension. Lancet, 2, 334.

Dollery

C. T.

Harington

(1962). Methyldopa in hypertension: clinical and pharmacological studies. Lancet, 1, 759.

Hamilton

Kopelman

(1963). Treatment of severe hypertension with methyldopa. Brit. med. J., 1, 151.

Keith

N. M.

Wagener

H. P.

Barker

N. W.

(1939). Some different types of essential hypertension: Their course and prognosis. Amer. J. Med. Sci., 197, 332.

Kincaid-Smith

McMichael

Murphy

E. A.

(1958). The clinical course and pathology of hypertension with papilledema (malignant hypertension). Quart. J. Med., 27, 117.

Leishman

A. W. D.

Matthews

H. L.

Smith

A. J.

(1961). Further experience with guanethidine. Lancet, 2, 4.

Lowther

C. P.

Turner

R. W. D.

(1963). Guanethidine in the treatment of hypertension. Brit. med. J., 2, 776.

Luke

R. G.

Kennedy

A. C.

(1964). Methyldopa in treatment of hypertension due to chronic renal disease. Brit. med. J., 1, 27.

10.

Palmer

K. N. V.

McDonald

G. A.

(1962). Guanethidine in the treatment of hypertension. Postgrad. med. J., 38, 338.